AbstractBackground Iron and its homeostasis are intimately related to inflammatory responses, but the underlying molecular mechanisms are poorly understood. We investigated the role of Steap3 in regulating iron homeostasis in macrophages, and the effects of Steap3 depletion on host inflammatory responses.Design and Methods We analyzed bone marrow-derived macrophages and primary cultured hepatocytes from Steap3-/- mouse models to investigate the roles of Steap3 in coordinately regulating iron homeostasis and inflammatory responses. First, we examined iron distribution and iron status in cells deficient in Steap3, as well as the requirement for the Steap3 gene during inflammatory responses. Secondly, we analyzed the regulation of Steap3 expression by inflammatory stimuli and thus, the influence of these stimuli on iron distribution and homeostasis.Results We found that Steap3 mRNA was expressed at high levels in macrophages and hepatocytes. Steap3 deficiency led to impaired iron homeostasis, causing abnormal iron distribution and a decreased availability of cytosolic iron in macrophages. Among STEAP family members, Steap3 mRNA was uniquely down-regulated in macrophages stimulated by lipopolysaccharides. To determine whether Steap3 regulated iron homeostasis during inflammatory stress, we treated Steap3-/- mice with lipopolysaccharide, which produced greater iron accumulation in the vital tissues of these mice compared to in the tissues of wild-type controls. Furthermore, Steap3 depletion led to impaired induction of interferon-β, monocyte chemoattractant protein-5, and interferon induced protein-10 in macrophages via the TLR4-mediated signaling pathway.Conclusions Steap3 is important in regulating both iron homeostasis and TLR4-mediated inflammatory responses in macrophages. Steap3 deficiency causes abnormal iron status and homeostasis, which leads to impaired TLR4-mediated inflammatory responses in macrophages. Following inflammatory stimuli, Steap3 depletion causes dysregulated iron sequestration and distribution. Our results provide important insights into the function of Steap3 as a coordinate regulator of both iron homeostasis and innate immunity.
In eukaryotes, iron exists in two valence states, ferrous (Fe) and ferric (Fe). Fe can bind to transferrin, the major carrier of iron in the circulation and extravascular fluid, to form holo-transferrin, which is taken up by receptor-mediated endocytosis of transferrin receptor on the cell membrane. The endosome containing transferrin-trasnferrin receptor-1 complex is then acidified, which facilitates release of ferric iron from holo-transferrin.1 However, ferric iron must be reduced to the ferrous form before it can be transported out to the cytoplasm by the divalent metal transporter-1 (DMT1)2,3 or transient receptor potential (TRP) protein TRPML1.4
Six-transmembrane epithelial antigen of the prostate 3 (Steap3) was recently characterized as a ferrireductase that reduces ferric iron to ferrous iron in endosomes.5,6 Steap3 belongs to the STEAP family, which bears homology to oxidoreductases found in bacteria and archaea as well as the FRE metalloreductase in yeast.5,6 There are four members in the STEAP family, Steap1, Steap2, Steap3, and Steap4.5 Although the four members of the STEAP family have different expression profiles, they are all localized to the plasma membrane and/or endosomes. In addition, all Steap proteins except Steap1 demonstrate ferrireductase activity when over-expressed in human embryonic kidney cells.5Steap3 was initially described as a putative tumor suppressor gene capable of inhibiting tumor cells through a caspase-3 dependent pathway.7-9 It was subsequently reported to facilitate exosome secretion via a non-classic pathway.10,11 Previous work in mouse models showed that a lack of Steap3 leads to a hypochromic, microcytic anemia and disrupts iron metabolism; this results in iron overload in serum and tissues.12 Recently, a nonsense mutation in the Steap3 gene was found to be associated with a novel type of congenital hypochromic anemia.13
Here we demonstrate that Steap3 is the only STEAP family member highly expressed in macrophages, a cell population that functions in innate immunity. The functional characteristics illustrate the crucial roles played by macrophages in both modulation of iron homeostasis and immune responses. During infections, available free iron is decreased and becomes sequestered in cells of the reticuloendothelial system, especially macrophages, due to inflammatory signaling cascades.14,15 Iron is required by host cells for normal cellular function and immune-mediated defense mechanisms. For example, iron homeostasis can affect the macrophage effector functions that influence downstream innate and adaptive immune responses.15,16
The interactions between iron status and immune function are well-described but poorly understood, particularly with regard to the molecular mechanisms that regulate these interactions. This study was conducted to investigate such interactions.
Design and Methods
The design and methods of this study are described in full in the Online Supplementary Design and Methods.5,6,17 Briefly, we used Steap3-/- mice and control wild-type Steap3+/+ mice provided with a standard rodent laboratory diet, injected intraperitoneally with a single dose of lipopolysaccharide (LPS) or the same volume of phosphate-buffered saline as a control. Blood and tissues were harvested for protein, iron and gene expression assays at various time points.
Data are presented as mean ± SEM. All experiments were performed in triplicate. Student's t-test was used for comparison between two groups. P values < 0.05 were considered statistically significant.
Steap3 is a ferrireductase and is highly expressed in macrophages and hepatocytes
Macrophages and hepatocytes are both important regulators of iron storage and metabolism. To investigate the roles played by the indispensable iron reductases, which control iron metabolism in these two cell types, we analyzed the expression of STEAP mRNA. Doing so revealed that the expression of Steap3 was over 200-fold higher in bone marrow derived macrophages (BMDMs) than Steap1, Steap2, and Steap4 in wild-type mice (Figure 1A). In primary cultured mouse hepatocytes, Steap3 was again the most highly expressed, while the other STEAP family members were expressed at similar levels to each other, and was expressed to a greater extent in these cells than in BMDMs (Figure 1B). We next examined Steap3-/- macrophages and hepatocytes to determine whether mRNA levels of the three other STEAP family members were altered, which would suggest possible compensatory regulation. The mRNA for Steap2 and Steap4, which have ferrireductase activity, was consistently and significantly up-regulated in macrophages in the absence of Steap3 (Figure 1C), however, the expression of Steap2 and Steap4 mRNA still did not reach the level of Steap3 expression in wild-type BMDMs. In Steap3 hepatocytes, Steap2 was significantly up-regulated, whereas Steap1 and Steap4 mRNA levels were unchanged (Figure 1D). Since Steap3 was the only highly expressed STEAP member in macrophages, this suggests that Steap3 might play an important role in these cells, which are responsible for both maintaining iron homeostasis and regulating inflammatory immune responses. Thus, we measured ferrireductase activity in BMDMs and hepatocytes from Steap3versus control mice, and found significant reductions in both the knockout BMDMs (Figure 1E) and the hepatocytes (Figure 1F).
Abnormal iron status in Steap3-/- macrophages and hepatocytes
As Steap3 was the only STEAP reductase family member that was highly expressed in macrophages, we investigated whether Steap3 depletion affects iron homeostasis and metabolism in macrophages. First, we analyzed the expression of important cellular iron transporters and regulators such as Hfe, HO-1, Fpn1 and Dmt1 in Steap3 BMDMs, because altered expression might influence net iron homeostasis. All four mRNA were similarly expressed in Steap3-/- and wild-type BMDMs (Online Supplementary Figure S1A). We then investigated whether Steap3 deficiency led to disturbances in macrophage iron homeostasis as indicated by iron distribution and content. Using scanning transmission X-ray microscopy spectromicroscopy analysis, we found that iron was present in a more concentrated distribution in Steap3-/- macrophages (compacted, pseudo-colored red plaques in Online Supplementary Figure S1B, right panel), than in Steap3+/+ macrophages (disperse, pseudo-colored red regions in Online Supplementary Figure S1B, left panel). The total iron content within whole cells was measured by inductively coupled plasma mass spectrometry. The results showed that total iron content was similar between Steap3 and Steap3 BMDMs, before or after treatment with ferric ammonium citrate (FAC) (Figure 2A). The cytochemical calcein-AM (calcein- acetoxymethyl ester) method is an established technique for assaying the ‘labile iron pool’ of cells.18,19 The calcein assay showed higher fluorescence in Steap3 BMDMs, indicating lower cytosolic iron (Figure 2B). Similar results were obtained when examining the protein levels of ferritin-H and ferritin-L, both of which are post-transcriptionally controlled by low cytosolic iron.20 Both before and after FAC treatment, ferritin levels were lower in Steap3 BMDMs than in wild-type cells (Figure 2C). Collectively, these data suggest that Steap3 mice could not reduce Fe to Fe for release into the cytoplasm, which caused unbalanced iron distribution as iron was congregated in some compartments, but also displayed lower available cytosolic iron, although the total cellular iron content was similar to that in the wild-type animals. Additionally, we performed the experiments in primary cultured hepatocytes. The results showed that the total iron content was higher in Steap3 hepatocytes than in Steap3 hepatocytes (Figure 2D). However, the calcein assay and ferritin protein levels all suggested similar cytosolic iron levels in these two hepatocyte populations (Figure 2E and 2F). We then analyzed the iron status in liver and spleen. The iron content of liver and spleen was higher in Steap3 mice than in wild-type mice (Figure 2G). However, in the liver, ferritin-H and ferritin-L levels were the same in both Steap3 and Steap3 mice, whereas in the spleen, ferritin-H and ferritin-L levels were both lower in Steap3 mice than in Steap3 ones (Figure 2H). Together, these results confirm that deficiency in Steap3 causes abnormal cellular iron status.
Steap3 is down-regulated by lipopolysaccharide in macrophages
Since macrophages play important roles in innate immune function, we investigated whether Steap3 contributed functionally to macrophage-mediated innate immunity. First, we determined whether Steap3 could be regulated by an infectious stimulus. We used LPS, an agonist for TLR4, to treat wild-type BMDMs for 24 h, and examined the relative mRNA levels of STEAP family members. Doing so revealed that Steap3 mRNA declined markedly after LPS treatment (Figure 3A). In contrast, Steap4 was up-regulated by LPS at a very early time point, consistent with reports that Steap4 could be up-regulated by tumor necrosis factor-alpha (TNF-α.).21Steap1 and Steap2 were also transiently increased after LPS stimulation (Online Supplementary Figure S2A).
To determine whether the down-regulation of Steap3 mRNA after LPS administration also existed in other types of cells, we treated wild-type hepatocytes with LPS as above. Surprisingly, Steap3 mRNA did not change with LPS treatment in hepatocytes (Figure 3B). However, we did find that Steap1, Steap2, and Steap4 were up-regulated by LPS, indicating a similar regulation pattern as in macrophages (Online Supplementary Figure S2B).
One possible explanation for the above results was that LPS-stimulated macrophages, but not hepatocytes, secreted unique factors22 that led to Steap3 mRNA down-regulation. To test this hypothesis, we incubated wild-type hepatocytes with culture medium from wild-type BMDMs that had been plated with or without LPS stimulation. When hepatocytes were cultured overnight in conditioned medium derived from macrophages plated without LPS stimulation, Steap3 mRNA remained unchanged in hepatocytes (Figure 3C). However, when hepatocytes were incubated with conditioned medium derived from macrophages stimulated overnight with LPS, we observed a striking down-regulation of Steap3 mRNA (Figure 3D). The same pattern of down-regulation was also found in primary cultured peritoneal macrophages (Figure 3E), as well as bulk bone marrow (Figure 3F), and liver preparations (Figure 3G) from LPS-stimulated mice. These results suggested that transcriptional regulation of Steap3 or mRNA stability after an inflammatory stimulus was different from that of other STEAP family members, and that Steap3 mRNA could be down-regulated by factors secreted by macrophages after LPS stimulation. As demonstrated above, Steap3 deficiency caused iron retention in cells, but simultaneously led to low availability of cytosolic iron. Collectively, these facts imply that down-regulation of Steap3 mRNA might contribute to the sequestration of iron in macrophages during inflammatory stimulation.
Systemic and cellular iron homeostasis are disturbed in Steap3-/- mice following lipopolysaccharide stimulation
To find out whether Steap3 played a part in the redistribution and sequestration of iron in mice during inflammatory conditions, we treated wild-type (8-week old, male) and Steap3-/- mice (8-week old, male) with LPS at a dose of 5 mg/kg for 3 or 6 h. In wild-type mice, serum iron and transferrin saturation were decreased after LPS treatment, and were accompanied by increased unsaturated iron-binding capacity (Figure 4A-4D), indicative of a link between iron and inflammatory responses known as anemia of inflammation.23 However, in Steap3 mice treated with LPS, serum iron concentrations, total iron-binding capacity and transferrin saturation only showed a marginally decreasing trend (P=0.08) at 6 h after LPS treatment (Figure 4A-4D).
As potential indicators of dysregulated iron homeostasis, we next examined iron content in livers and spleens of Steap3 mice. In Steap3 mice, the liver iron content after LPS stimulation was markedly increased compared to that in wild-type mice, (Figure 4E). In Steap3 mice, splenomegaly was present even before LPS treatment, and spleens remained enlarged after LPS stimulation (Figure 4F). The splenic iron concentrations in Steap3 mice were higher than those in control mice (Figure 4G). The total iron content in Steap3 spleens was also greater than that present in control mice, both before and after LPS treatment (Figure 4H). As an important hormonal regulator of systemic iron homeostasis, we examined hepcidin mRNA expression, which is encoded by Hamp1, in wild-type and Steap3-deficient mice before and after LPS stimulation. Whereas wild-type mice showed a significant increase in Hamp1 mRNA at 3 h post-LPS stimulation, Steap3 mice showed a relatively mild increase in hepcidin (Figure 4I). This observation might account for the uniform serum iron concentrations observed in knock-out mice (Figure 4A), since low hepcidin expression could cause increased iron uptake in the duodenum via enhanced expression of Fpn1.1 We also investigated the serum concentrations of pro-inflammatory cytokines TNF-α and interleukin 6 (IL- 6), both of which were significantly higher in Steap3 mice treated with LPS for 3 h than in control mice (Figure 4J, 4K). Additionally, we examined the mRNA level of TNF-α and IL-6 in livers since hepatic inflammatory responses are also physiologically important. The levels of TNF-α (Online Supplementary Figure S3A) were the same in both wild-type and Steap3 mice, while the concentration of IL-6 (Online Supplementary Figure S3B) was slightly higher in Steap3 mice than in wild-type ones. These results indicate that Steap3 depletion could affect the redistribution of iron in serum and tissues and support our hypothesis that Steap3 might function in regulating infection-induced sequestration of iron.
TLR4-mediated inflammatory responses are impaired in Steap3-/- macrophages
Since we demonstrated that inflammatory stimuli could alter iron distribution in a manner that was partially due to Steap3, we then investigated how abnormal iron status in Steap3 mice could affect the inflammatory responses in macrophages. We treated BMDMs from wild-type and Steap3 mice with LPS and analyzed the mRNA expression of several pro-inflammatory factors over time. Following LPS administration, TNF-α (Figure 5A) and IL-6 (Figure 5B) were up-regulated to similar levels in Steap3 macrophages and their wild-type counterparts. IFN-β was dramatically diminished in Steap3 macrophages following LPS stimulation (Figure 5C). The phosphorylation of STAT1 downstream of IFN-β was consistently impaired after LPS stimulation in Steap3 macrophages (Figure 5G). Not surprisingly, the expression of MCP-5 (Figure 5D), IP- 10 (Figure 5E) and RANTES (Figure 5F) was decreased as well, since they function downstream of IFN-β. IFN-β can be induced by LPS via a TLR4-mediated, Myd88-dependent pathway, or by poly(I:C) via a TLR3-mediated, Myd88-independent pathway.24,25 We treated BMDMs with the TLR2 agonist Pam3CSK4 or the TLR3 agonist poly(I:C), which induce inflammatory responses through Myd88-dependent and Myd88-independent pathways, respectively,25,26 to identify which IFN-β-inducing pathway was impaired in Steap3 macrophages. As expected, Pam3CSK4 could not induce IFN-β, MCP-5, or IP-10. However, following poly(I:C) treatment, which could trigger the TLR3-mediated, Myd88-independent pathway, there were no differences in the expression of TNF-α, IL- 6, IFN-β, MCP-5, IP-10, or RANTES between Steap3 or Steap3 macrophages (Figure 5A-5F). Of note, the poly (I:C)-induced phosphorylation of STAT1 was also equivalent between wild-type and knock-out macrophages (Figure 5G). Despite the fact that poly(I:C) and LPS could both induce IFN-β through a Myd88-independent pathway using the same adaptor protein, TIR-domain-containing adapter inducing interferon-β (TRIF), TLR3 and TLR4 have different adaptors for signal transduction. MyD88-independent IFN-β production and activation of signaling cascades are TRIF-related adaptor molecule (TRAM)-dependent in TLR4-mediated signaling, while they are TRAM-independent in TLR3-mediated induction. 27 Our results show that depletion of Steap3 might specifically impair the TLR4-mediated, Myd88-independent pathway. This finding further confirmed the function of Steap3 as a coordinate regulator of both iron metabolism and inflammatory responses.
Deletion of Steap3 inhibited iron-enhanced TLR4-mediated inflammatory responses
Our results to this point showed an impaired TLR4- mediated, TRIF/TRAM-dependent inflammatory response and abnormal iron status, indicated by low availability of cytosolic iron in Steap3 macrophages. To confirm the role of iron in this TLR4-mediated pathway, we treated wild-type and Steap3 macrophages with FAC. FAC treatment significantly enhanced TLR4-mediated inflammatory responses, evidenced by increased expression of IFN-β, MCP-5, and IP-10 (Figure 6A-6C), and increased phosphorylation of STAT1 (Figure 6D). Consistent with the above results, these cytokines were decreased in Steap3 mice with or without FAC treatment, as was the phosphorylation of STAT1. These results further confirmed that low cytosolic available iron in Steap3 macrophages could impair TLR4-mediated cellular inflammatory responses.
Iron and its homeostasis are intimately related to inflammatory responses and, therefore, provide major protective mechanisms in human physiology. However, the molecular basis for the interaction between iron and immune function is not well understood. In the past decade, a large number of experimental studies showed that responses to inflammation and susceptibility to infection worsen with iron overload. Hereditary hemochromatosis with iron overload has been reported to confer susceptibility to infectious pathogens, while iron deficiency confers relative resistance to infection.28-30 Here we demonstrated that the ferrireductase Steap3 is a coordinate regulator of inflammatory responses and iron homeostasis.
In the current study, we found that Steap3 was the only STEAP family member that is highly expressed in macrophages, an important type of cell that links iron homeostasis and inflammatory responses. Furthermore, we demonstrated that Steap3 acts as a ferrireductase in macrophages and hepatocytes. Conceivably, in Steap3- depleted cells, ferric iron could not be reduced to ferrous iron, which is the only form able to be transported to the cytoplasm. Thus, iron might be accumulated in endosomes and lysosomes, accompanied by decreased cytosolic iron. As expected, we found that available cytosolic iron was lower in Steap3 BMDMs than wild-type BMDMs, although both strains had similar cellular iron content. Steap3 hepatocytes had higher total cellular iron but the same cytosolic iron compared to wild-type hepatocytes, which might be due to the compensatory effects of the relatively high expression of Steap2 and Steap4. Notably, after FAC treatment, both Steap3 BMDMs and hepatocytes could still increase cytosolic iron even though the transport mechanism from endosome to cytosol was blocked. This might be due to involvement of other pathways of iron uptake, such as non-transferrin bound iron, which does not go through the endosome reducing pathway. We sought to understand the function of Steap3 in the regulation of iron homeostasis and inflammatory responses by focusing initially on two aspects. First, we determined how an inflammatory stimulus altered iron status and sequestration of iron. Second, we examined how the disturbance of iron status affected inflammatory responses.
To answer the first question, we found a specific down-regulation of Steap3 mRNA after LPS stimulation, which was the opposite of the transient spikes in other Steap mRNA. Furthermore, while the up-regulation by LPS of other STEAP family members was also observed in hepatocytes, Steap3 expression was not changed in these cells. This observation implied that secreted factors from macrophages are required for down-regulation of Steap3 under inflammatory conditions. We then confirmed this hypothesis by incubating hepatocytes with LPS-treated conditioned medium from BMDMs, which resulted in down-regulation of Steap3. Identification of the specific soluble factors secreted from macrophages which cause Steap3 down-regulation will require further study. TNF-α and IL-6 are not likely to be the regulators because, like macrophages, hepatocytes can also secrete TNF-α and IL- 6 (data not shown).
Combined with the fact that iron was retained in Steap3-deficient cells, these results implied that down-regulation of Steap3 might be a requisite for the sequestration of iron during inflammatory stimulation. This was further confirmed in LPS-challenged mice. We found abnormal iron distribution in serum and tissues of Steap3 mice after LPS stimulation compared to the distribution in wild-type controls. Steap3 mice expressed less liver hepcidin than wild-type mice after LPS stimulation, which could cause high expression of Fpn1 in the duodenum leading to enhanced uptake of iron. This might partially account for the unchanged serum iron and transferrin saturation in Steap3 mice. These findings would complement other known iron sequestration mechanisms through posttranslational down-regulation of FPN1, mediated by the increased circulating levels of hepcidin associated with infection,31 and mechanisms mediated by Nramp1, lactoferrin, and siderocalin, which have well-described functions in innate immunity.32-35
With regards to the second question, we hypothesized that depletion of Steap3 might cause abnormal inflammatory responses in macrophages. To confirm this, we used LPS to treat BMDM. The results showed that IFN-β induction in Steap3 macrophages was severely impaired compared to that in controls. LPS-induced up-regulation of IFN-β was mediated by TRAM/TRIF signals through a TLR4-mediated, Myd88-independent signal transduction pathway.36,37 There was no significant difference between control and Steap3 macrophages with regard to poly(I:C)- induced expression of IFN-β mRNA. This observation suggests that the functions of TRIF and signal transducing molecules distal to TRIF are unaffected by Steap3 deficiency.
There are several aspects of the TLR4-specific activation of TRIF-dependent signals that could be affected by Steap3 deficiency in macrophages, including abnormal cellular iron distribution, TLR4 endocytosis, TRAM endocytosis, TLR4/TRAM interactions, TRAM expression, and TRAM/TRIF interactions.38 Steap3 might take part in these processes directly. Previous work had shown that Hfe, a gene that encodes the human hemochromatosis protein, whose deficiency leads to low cellular iron, might contribute to impair signaling through the TRAM/TRIF pathway.39 In our study, although we observed the same iron content in Steap3 macrophages, the cytosolic available iron was much lower as the expression of ferritin was decreased in Steap3 macrophages before and after stimulation by either LPS or poly(I:C) (Online Supplementary Figure S2A, B). This may have led to impaired activation of the TRAM/TRIF pathway. The high iron concentrations could have enhanced TLR4-mediated, TRAM/TRIF-dependent pathways as we observed that the expression of IFN-β, MCP-5, IP-10 and phosphorylation of STAT1 were significantly enhanced after treatment with FAC during LPS stimulation.
In both TRAM knock-out mice and TRIF knock-out mice, impairment of the TRAM/TRIF-dependent pathway led to decreased production of TNF-α, IL-6, and IFN-β.25,27 However, TNF-α and IL-6, which could also be induced by a TRAM/TRIF pathway other than the Myd88-dependent one, were not decreased in Steap3 macrophages after LPS stimulation. We suspect that the low cytosolic iron in Steap3 macrophages might contribute to the impaired production of IFN-β. Further investigation is required to determine whether Steap3 is involved in the TLR4-mediated, Myd88-dependent signaling pathway. The most likely mechanism by which Steap3 might regulate TLR4 signaling is through altered endocytosis of TLR440 in the absence of Steap3, resulting in more TLR4 in the cell membrane after LPS stimulation. Thus, the impaired TRAM/TRIF-dependent pathway might be accompanied by competitive enhancement of the Myd88-dependent pathway. These proposed mechanisms will need to be confirmed by further investigations. Future studies will be required to determine whether Steap3 itself or other STEAP family members are directly involved in these inflammatory responses.
It seemed paradoxical that inactivation of Steap3 led to impaired TLR4-mediated inflammatory responses when Steap3 could be down-regulated by LPS. It is possible that due to negative feedback Steap3 is down-regulated by LPS in order to decrease the inflammatory response. Furthermore, we used different stimuli including poly(I:C) (a TLR3 agonist) and pam3CSK4 (a TLR2 agonist), and found that in both cases Steap3 could be down-regulated. However, IFN-β expression was the same in wild-type and Steap3 macrophages stimulated with poly(I:C). Thus, the down-regulation of Steap3 by stimulation seemed to be independent of the impaired inflammatory responses caused by decreased cytosolic iron. We propose that this might be part of a protective mechanism resembling the way that Fpn1 allows organisms to keep iron in the cell in order to avoid it being used by pathogens such as bacteria or viruses. Though the down-regulation of Steap3 might not be related to the TLR4-mediated pathway, we could not exclude the possibility that Steap3 takes part in the TLR4 signaling pathway.
In conclusion, our findings revealed important roles for Steap3 in the coordinate regulation of iron homeostasis and inflammatory responses, which helps to shed light on interactions between iron homeostasis and innate immunity.
we are grateful to Dr. M. D. Fleming at Harvard Medical School for providing Steap3 knockout mice and XZ Zhang at the beamline 08U1-A at the Shanghai Synchrotron Radiation Facility for on-site assistance.
Funding: this work was supported by research grants from the Ministry of Science and Technology of China (973 Program) (grant n. 2009CB941404, 2011CB96620ô 2012BAD33B05 to FW); the National Natural Science Foundation of China (grant n. 31030039, 10979071, 30970665 and 31225013 to FW, 31200892 to ZZ, 30901193 to YY); Science & Technology Commission of Shanghai Municipality grant (grant n. 10JC1416800 to FW); an Outstanding Youth Fellowship (grant n. 2010KIP309 to YY), the Knowledge Innovation Program (grant n. 2012KIP402 to PA) and the Postdoctoral Fellowship Program (grant n. 2012KIP512 to ZZ) of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences; a China Postdoctoral Science Foundation Fellowship (grant n. 2012M510902 to YY). We appreciate the encouragement and helpful comments from other members of the Wang's laboratory.
- The online version of this article has a Supplementary Appendix.
- Authorship and Disclosures: The information provided by the authors about contributions from persons listed as authors and in acknowledgments is available with the full text of this paper at www.haematologica.org. Financial and other disclosures provided by the authors using the ICMJE (www.icmje.org) Uniform Format for Disclosure of Competing Interests are also available at www.haematologica.org.
- Received February 8, 2012.
- Revision received May 24, 2012.
- Accepted May 30, 2012.
- Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of mammalian iron metabolism. Cell. 2010; 142(1):24-38. PubMedhttps://doi.org/10.1016/j.cell.2010.06.028Google Scholar
- Fleming MD, Romano MA, Su MA, Garrick LM, Garrick MD, Andrews NC. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci USA. 1998; 95(3):1148-53. PubMedhttps://doi.org/10.1073/pnas.95.3.1148Google Scholar
- Fleming MD, Trenor CC, Su MA, Foernzler D, Beier DR, Dietrich WF. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet. 1997; 16(4):383-6. PubMedhttps://doi.org/10.1038/nm0497-383Google Scholar
- Dong XP, Cheng X, Mills E, Delling M, Wang F, Kurz T. The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel. Nature. 2008; 455(7215):992-6. PubMedhttps://doi.org/10.1038/nature07311Google Scholar
- Ohgami RS, Campagna DR, McDonald A, Fleming MD. The Steap proteins are metalloreductases. Blood. 2006; 108(4):1388-94. PubMedhttps://doi.org/10.1182/blood-2006-02-003681Google Scholar
- Ohgami RS, Campagna DR, Greer EL, Antiochos B, McDonald A, Chen J. Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nat Genet. 2005; 37(11):1264-9. PubMedhttps://doi.org/10.1038/ng1658Google Scholar
- Zhang X, Steiner MS, Rinaldy A, Lu Y. Apoptosis induction in prostate cancer cells by a novel gene product, pHyde, involves caspase-3. Oncogene. 2001; 20(42):5982-90. PubMedhttps://doi.org/10.1038/sj.onc.1204831Google Scholar
- Rinaldy AR, Menon RP, Lerner JL, Steiner MS. Role of pHyde novel gene product as an intrinsic factor for apoptotic pathway in prostate cancer. Gan To Kagaku Ryoho. 2000; 27(Suppl 2):215-22. PubMedGoogle Scholar
- Passer BJ, Nancy-Portebois V, Amzallag N, Prieur S, Cans C, Roborel de Climens A. The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase. Proc Natl Acad Sci USA. 2003; 100(5):2284-9. PubMedhttps://doi.org/10.1073/pnas.0530298100Google Scholar
- Amzallag N, Passer BJ, Allanic D, Segura E, Thery C, Goud B. TSAP6 facilitates the secretion of translationally controlled tumor protein/histamine-releasing factor via a nonclassical pathway. J Biol Chem. 2004; 279(44):46104-12. PubMedhttps://doi.org/10.1074/jbc.M404850200Google Scholar
- Lespagnol A, Duflaut D, Beekman C, Blanc L, Fiucci G, Marine JC. Exosome secretion, including the DNA damageinduced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3- null mice. Cell Death Differ. 2008; 15(11):1723-33. PubMedhttps://doi.org/10.1038/cdd.2008.104Google Scholar
- Ohgami RS, Campagna DR, Antiochos B, Wood EB, Sharp JJ, Barker JE. nm1054: a spontaneous, recessive, hypochromic, microcytic anemia mutation in the mouse. Blood. 2005; 106(10):3625-31. PubMedhttps://doi.org/10.1182/blood-2005-01-0379Google Scholar
- Grandchamp B, Hetet G, Kannengiesser C, Oudin C, Beaumont C, Rodrigues-Ferreira S. A novel type of congenital hypochromic anemia associated with a nonsense mutation in the STEAP3/TSAP6 gene. Blood. 2011; 118(25):6660-6. PubMedhttps://doi.org/10.1182/blood-2011-01-329011Google Scholar
- Bullen JJ, Rogers HJ, Spalding PB, Ward CG. Natural resistance, iron and infection: a challenge for clinical medicine. J Med Microbiol.. 2006; 55(Pt3):251-8. PubMedhttps://doi.org/10.1099/jmm.0.46386-0Google Scholar
- Schaible UE, Kaufmann SH. Iron and microbial infection. Nat Rev Microbiol. 2004; 2(12):946-53. PubMedhttps://doi.org/10.1038/nrmicro1046Google Scholar
- Theurl I, Fritsche G, Ludwiczek S, Garimorth K, Bellmann-Weiler R, Weiss G. The macrophage: a cellular factory at the interphase between iron and immunity for the control of infections. Biometals. 2005; 18(4):359-67. PubMedhttps://doi.org/10.1007/s10534-005-3710-1Google Scholar
- Zhang Z, Zhang F, An P, Guo X, Shen Y, Tao Y. Ferroportin1 deficiency in mouse macrophages impairs iron homeostasis and inflammatory responses. Blood. 2011; 118(7):1912-22. PubMedhttps://doi.org/10.1182/blood-2011-01-330324Google Scholar
- Kakhlon O, Cabantchik ZI. The labile iron pool: characterization, measurement, and participation in cellular processes(1). Free Radic Biol Med.. 2002; 33(8):1037-46. PubMedhttps://doi.org/10.1016/S0891-5849(02)01006-7Google Scholar
- Glickstein H, El RB, Shvartsman M, Cabantchik ZI. Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells. Blood. 2005; 106(9):3242-50. PubMedhttps://doi.org/10.1182/blood-2005-02-0460Google Scholar
- Muckenthaler MU, Galy B, Hentze MW. Systemic iron homeostasis and the ironresponsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu Rev Nutr.. 2008; 28:197-213. PubMedhttps://doi.org/10.1146/annurev.nutr.28.061807.155521Google Scholar
- Wellen KE, Fucho R, Gregor MF, Furuhashi M, Morgan C, Lindstad T. Coordinated regulation of nutrient and inflammatory responses by STAMP2 is essential for metabolic homeostasis. Cell. 2007; 129(3):537-48. PubMedhttps://doi.org/10.1016/j.cell.2007.02.049Google Scholar
- Verga Falzacappa MV, Vujic Spasic M, Kessler R, Stolte J, Hentze MW, Muckenthaler MU. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood. 2007; 109(1):353-8. PubMedhttps://doi.org/10.1182/blood-2006-07-033969Google Scholar
- Wessling-Resnick M. Iron homeostasis and the inflammatory response. Annu Rev Nutr.. 2010; 30:105-22. PubMedhttps://doi.org/10.1146/annurev.nutr.012809.104804Google Scholar
- Zughaier SM, Zimmer SM, Datta A, Carlson RW, Stephens DS. Differential induction of the toll-like receptor 4- MyD88-dependent and -independent signaling pathways by endotoxins. Infect Immun.. 2005; 73(5):2940-50. PubMedhttps://doi.org/10.1128/IAI.73.5.2940-2950.2005Google Scholar
- Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science. 2003; 301(5633):640-3. PubMedhttps://doi.org/10.1126/science.1087262Google Scholar
- Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol. 2001; 1(2):135-45. PubMedhttps://doi.org/10.1038/35100529Google Scholar
- Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K, Kaisho T. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol. 2003; 4(11):1144-50. PubMedhttps://doi.org/10.1038/ni986Google Scholar
- Bullen JJ, Spalding PB, Ward CG, Gutteridge JM. Hemochromatosis, iron and septicemia caused by Vibrio vulnificus. Arch Intern Med.. 1991; 151(8):1606-9. PubMedhttps://doi.org/10.1001/archinte.1991.00400080096018Google Scholar
- Doherty CP. Host-pathogen interactions: the role of iron. J Nutr.. 2007; 137(5):1341-4. PubMedGoogle Scholar
- Gerhard GS, Levin KA, Price Goldstein J, Wojnar MM, Chorney MJ, Belchis DA. Vibrio vulnificus septicemia in a patient with the hemochromatosis HFE C282Y mutation. Arch Pathol Lab Med.. 2001; 125(8):1107-9. PubMedGoogle Scholar
- Andrews NC, Schmidt PJ. Iron homeostasis. Annu Rev Physiol. 2007; 69:69-85. PubMedhttps://doi.org/10.1146/annurev.physiol.69.031905.164337Google Scholar
- Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophoremediated iron acquisition. Mol Cell. 2002; 10(5):1033-43. PubMedhttps://doi.org/10.1016/S1097-2765(02)00708-6Google Scholar
- Marquis JF, Gros P. Genetic analysis of resistance to infections in mice: A/J meets C57BL/6J. Curr Top Microbiol Immunol. 2008; 321:27-57. PubMedhttps://doi.org/10.1007/978-3-540-75203-5_2Google Scholar
- Wang L, Cherayil BJ. Ironing out the wrinkles in host defense: interactions between iron homeostasis and innate immunity. J Innate Immun.. 2009; 1(5):455-64. PubMedhttps://doi.org/10.1159/000210016Google Scholar
- Ward PP, Paz E, Conneely OM. Multifunctional roles of lactoferrin: a critical overview. Cell Mol Life Sci.. 2005; 62(22):2540-8. PubMedhttps://doi.org/10.1007/s00018-005-5369-8Google Scholar
- O'Neill LA. The interleukin-1 receptor/Tolllike receptor superfamily: 10 years of progress. Immunol Rev.. 2008; 226:10-8. PubMedhttps://doi.org/10.1111/j.1600-065X.2008.00701.xGoogle Scholar
- Kawai T, Akira S. Toll-like receptor and RIG-I-like receptor signaling. Ann NY Acad Sci.. 2008; 1143:1-20. PubMedhttps://doi.org/10.1196/annals.1443.020Google Scholar
- Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol. 2008; 9(4):361-8. PubMedhttps://doi.org/10.1038/ni1569Google Scholar
- Wang L, Harrington L, Trebicka E, Shi HN, Kagan JC, Hong CC. Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice. J Clin Invest.. 2009; 119(11):3322-8. PubMedGoogle Scholar
- Husebye H, Halaas O, Stenmark H, Tunheim G, Sandanger O, Bogen B. Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity. EMBO J. 2006; 25(4):683-92. PubMedhttps://doi.org/10.1038/sj.emboj.7600991Google Scholar